Price $66.81 |
Market Cap
8.28B
|
Sector Health Care |
Div. Growth
11.10%
|
|
P/E
27.2
|
P/B
7.01
|
P/S
3.06
|
Dividend %
0.30%
|
|
P/CF
-
|
P/FCF
50.8
|
Op. Cash Flow
341.5K
|
FCF
1.1
|
|
Op. Margin
16.10%
|
Net Margin
11.30%
|
ROE
28.60%
|
ROI
13.60%
|
|
ROA
8.80%
|
EPS Growth
19.30%
|
Current Ratio
2.3
|
Debt/Equity
107.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Owens & Minor, Inc. (OMI) | $14.82 | - | - | 1.19B | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $13.24 | - | - | 78M | Strong Buy |
| Chromadex Corp (CDXC) | $3.07 | - | - | 105.8M | Strong Buy |
| Myomo Inc (MYO) | $5.03 | - | - | 35.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
